madman
Super Moderator
Tolmar Pharmaceuticals celebrated both the grand opening of its Canadian headquarters in Burlington and five years of expanding into the country last night as the company prepares to take next steps into the local market.
Tolmar is a global specialty pharmaceutical company that was founded in the U.S.A. but has since spread to around 88 countries. The company currently produces Eligard, which is used for prostate cancer management, and Fensolvi, which is used to treat Central Precocious Puberty (CPP) in young children, as well as their newest product Jatenzo for use in testosterone replacement.
